- Trials with a EudraCT protocol (224)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (7)
224 result(s) found for: Nitric oxide.
Displaying page 1 of 12.
EudraCT Number: 2010-023529-39 | Sponsor Protocol Number: RHM CHI 0548 | Start Date*: 2011-02-18 |
Sponsor Name:Southampton University Hopsitals NHS Trust | ||
Full Title: Reducing antibiotic tolerance using low dose nitric oxide in cystic fibrosis – a phase 2 pilot study | ||
Medical condition: Cystic Fibrosis | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2005-000326-24 | Sponsor Protocol Number: INOT41 | Start Date*: 2005-10-27 | |||||||||||
Sponsor Name:INO Therapeutics | |||||||||||||
Full Title: The Effects of Nitric Oxide for Inhalation during Left Ventricular Assist Device (LVAD) Implantation. | |||||||||||||
Medical condition: Acute right ventricular failure. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000625-30 | Sponsor Protocol Number: INOT22 | Start Date*: 2004-07-21 |
Sponsor Name:INO Therapeutics | ||
Full Title: Comparison of Supplemental Oxygen and Nitric Oxide for Inhalation Plus Oxygen in the Evaluation of the Reactivity of the Pulmonary Vasculature During Acute Pulmonary Vasodilator Testing | ||
Medical condition: : Nitric Oxide for inhalation at 800ppm, plus 100% O2, to be used to assess pulmonary vaso reactivity during Pulmonary Vasodilator Testing | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Completed) GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-005678-61 | Sponsor Protocol Number: ESNOD-01 | Start Date*: 2006-02-22 |
Sponsor Name:University Hospital Tuebingen | ||
Full Title: Entwicklung einer Untersuchungsmethode zur Bestimmung des NO-Transferfaktors der Lunge Evaluierung der Methode und Normwerterhebung an gesunden Probanden (Development of a new method for steady-sta... | ||
Medical condition: Lung function testing (NO- and CO Transferfactor) in healthy subjects | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-004928-12 | Sponsor Protocol Number: VICER1 | Start Date*: 2005-03-03 |
Sponsor Name:INO Therapeutics AB | ||
Full Title: A pilot, unicenter, prospective, aleatorized, with parallel groups, controlled and open to evaluate the efficacy of the Nitric Oxide for Inhalation in the prevention of reperfusion in pulmonary donor | ||
Medical condition: pulmonary graft dysfunction | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-000338-23 | Sponsor Protocol Number: 16013 | Start Date*: 2016-03-21 |
Sponsor Name:University of Nottingham | ||
Full Title: Does a low exhaled Nitric Oxide level exclude a clinical benefit from inhaled corticosteroids in suspected asthma; a double-blind, randomised, placebo controlled trial. | ||
Medical condition: suspected asthma people with asthma like symptoms | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-001525-28 | Sponsor Protocol Number: ICL-INONAC1 | Start Date*: 2006-03-24 |
Sponsor Name:Imperial College London | ||
Full Title: INFLUENCE OF THE ANTIOXIDANT N-ACETYLCYSTEINE ON INHALED NITRIC OXIDE INDUCED PULMONARY RESPONSES FOLLOWING HUMAN LUNG ISCHAEMIA-REPERFUSION INJURY | ||
Medical condition: heart-lung transplantation | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2007-000936-21 | Sponsor Protocol Number: 2007LF004B | Start Date*: 2007-09-10 | |||||||||||
Sponsor Name:Royal Brompton | |||||||||||||
Full Title: THE EFFECT ON ALVEOLAR NITRIC OXIDE OF SALMETEROL, FLUTICASONE, AND IN COMBINATION, IN STABLE BRONCHIECTASIS. | |||||||||||||
Medical condition: bronchiectasis. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001490-68 | Sponsor Protocol Number: NCT04306393 | Start Date*: 2020-04-15 | |||||||||||
Sponsor Name:Stockholm County Council; Danderyd Hospital | |||||||||||||
Full Title: Inhaled Nitric Oxide Gas Therapy in Mechanically Ventilated Patients with Severe Acute Respiratory Syndrome in COVID-19 | |||||||||||||
Medical condition: COVID-19 infection caused by SARS-CoV-2 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001329-30 | Sponsor Protocol Number: 2020P000787 | Start Date*: 2020-04-09 |
Sponsor Name:Massachussetts General Hospital | ||
Full Title: Inhaled Nitric Oxide Gas Therapy in Mechanically Ventilated Patients with Severe Acute Respiratory Syndrome in COVID-19 | ||
Medical condition: ARDS caused by COVID-19 infection | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2008-006776-29 | Sponsor Protocol Number: 081016 | Start Date*: 2009-02-18 |
Sponsor Name:Karolinska Institutet | ||
Full Title: NO som behandling vid knäproteskirurgi. Studie med avseende på anti-inflammatorisk modulation hos patienter som genomgår operation med ryggbedövning. | ||
Medical condition: Patienter som skall genomgå knäprotesoperation och skall ha bedövning i form av ryggbedövning (spinalanestes/epiduralanestesi). | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-001287-36 | Sponsor Protocol Number: CTP-5 | Start Date*: 2008-06-16 | |||||||||||
Sponsor Name:Nitric BioTherapeutics, Inc | |||||||||||||
Full Title: A Phase II Trial on the Reduction of Meticillin Resistant Staphylococcus Aureus in MRSA Positive Ulcers | |||||||||||||
Medical condition: Ulcers in which the presence of meticillin resistant Staphylococcus aureus (MRSA) has been identified. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-004994-27 | Sponsor Protocol Number: 2020SW03 | Start Date*: 2020-12-16 |
Sponsor Name:Ashford and St Peter's Hospitals NHS Foundation Trust | ||
Full Title: Clinical Efficacy of Nitric Oxide Nasal Spray (NONS) for the Treatment of Mild COVID-19 Infection | ||
Medical condition: COVID-19 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2014-001029-34 | Sponsor Protocol Number: 2014-BUDFOR-EL-47 | Start Date*: 2015-10-07 |
Sponsor Name:ELPEN Pharmaceutical Co. Inc | ||
Full Title: Evaluation of the effect of the inhaled combination budesonide -formoterol (Pulmoton® Elpenhaler®) in exhaled nitric oxide (FeNO) of patients with bronchial asthma. | ||
Medical condition: Bronchial Asthma | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2004-002312-29 | Sponsor Protocol Number: INOT -27 | Start Date*: 2005-01-10 | |||||||||||
Sponsor Name:INO Therapeutics | |||||||||||||
Full Title: The Effects of Nitric Oxide for Inhalation on the development of chronic lung disease in pre-term infants. | |||||||||||||
Medical condition: Prevention of chronic lung disease in pre-term infants ( gestational age < 29 weeks) with respiratory distress. | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) SE (Completed) GB (Completed) DE (Completed) BE (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-004614-16 | Sponsor Protocol Number: DIA-ALE-2004-01 | Start Date*: 2005-09-29 |
Sponsor Name:DIATER LABORATORIES S.A. | ||
Full Title: Alternaria alternata inmunotherapy effects on AMP and methacholine bronchial answer and on inflammation markers in exhaled air (nitric oxide) and in condensated air (pH and hydrogen peroxide) in a... | ||
Medical condition: Asthma and allergic rhinitis | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-003884-37 | Sponsor Protocol Number: RONIN-CCV | Start Date*: 2023-05-26 |
Sponsor Name:Fernando Suarez Sipmann | ||
Full Title: Role of inhaled nitric oxide on right ventricular function and pulmonary vascular mechanics following cardiac surgery | ||
Medical condition: Patients in the immediate cardiac surgery post-operative period | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004684-12 | Sponsor Protocol Number: iNO_Protocol_V1.1_16.07.17 | Start Date*: 2019-05-16 |
Sponsor Name:Lady Cilento Children's Hospital | ||
Full Title: Nitric Oxide during Cardio Pulmonary Bypass during surgery for congenital heart defects: A Randomised Controlled Trial. | ||
Medical condition: Congenital heart disease ranks still within the top causes of infant mortality in industrialized countries. Despite considerable advances over the past decade, the exposure to cardiopulmonary bypas... | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-003338-15 | Sponsor Protocol Number: RBHP2014ELJEZI | Start Date*: 2014-12-01 | |||||||||||
Sponsor Name:CHU de Clermont-Ferrand | |||||||||||||
Full Title: Role of Nitric Oxide (NO) in pre-oxygenation before anesthetic induction in patients with Pulmonary Hypertension (PH) in cardiac surgery. Feasibility study. | |||||||||||||
Medical condition: - Cardiac surgery open heart - Pulmonary Hypertension with PAPs> 40 mmHg secondary to left heart disease or COPD (class 2 or 3), diagnosed by preoperative right heart catheterization or transthora... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002931-95 | Sponsor Protocol Number: LCC2010.01 | Start Date*: 2008-01-30 | |||||||||||
Sponsor Name:UZ Leuven | |||||||||||||
Full Title: The Effects of Nitric Oxide for Inhalation on Myocardial Infarction Size. | |||||||||||||
Medical condition: Myocardial Infarction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) DE (Prematurely Ended) HU (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
